Category: Psychedelics

Read More

Tryp Therapeutics merger with Exopharm approved by shareholders

Clinical-stage psychedelic biotech, Tryp Therapeutics, Inc., has announced that its previously announced plan to merge with Exopharm Limited has received approval from Exopharm’s shareholders. The arrangement, which is expected to close on or about May 1, has satisfied all conditions precedent, with the exception of the conditional approval from the …